1. Home
  2. TENX vs ORBS Comparison

TENX vs ORBS Comparison

Compare TENX & ORBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$14.82

Market Cap

317.8M

Sector

Health Care

ML Signal

HOLD

Logo Eightco Holdings Inc.

ORBS

Eightco Holdings Inc.

HOLD

Current Price

$0.58

Market Cap

262.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TENX
ORBS
Founded
1967
1966
Country
United States
United States
Employees
N/A
9
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.8M
262.0M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
TENX
ORBS
Price
$14.82
$0.58
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
1.3M
11.6M
Earning Date
05-15-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.80
$0.57
52 Week High
$19.40
$15.96

Technical Indicators

Market Signals
Indicator
TENX
ORBS
Relative Strength Index (RSI) 49.73 35.56
Support Level $13.13 $0.57
Resistance Level $16.35 $1.23
Average True Range (ATR) 1.20 0.05
MACD -0.22 0.00
Stochastic Oscillator 19.95 4.77

Price Performance

Historical Comparison
TENX
ORBS

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About ORBS Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Corrugated Packaging Business manufactured and sold custom packaging for a wide products and through packaging helps customers generate brand awareness and promote brand image. Generate the substantial majority of revenues from inventory financing and inventory management services.

Share on Social Networks: